GLPwatch
Trials (2101)
Page 30 of 36.
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- Study on Lixisenatide and Counterregulation to Hypoglycemia
- A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
- Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- Bioenergetic Alterations After Exenatide Administration
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
- Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
- A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
- A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Effect of Itopride on Semaglutide Gastroparesis
- Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
- Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- Exendin PET/CT for Imaging of Paragangliomas
- Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
- A Study of TG103 Injection in Type 2 Diabetes Subjects
- Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
- GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
- Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
- A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
- Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Incretin Therapies in Obesity-related HFpEF
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
- The Effect of Semaglutide on Cardiovascular Markers and Liver Function
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
- Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
- Effects of GLP-1 RAs on Human Lactation Outcomes
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
- A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- Body Surface Gastric Mapping in Patients on Semaglutide